Status:
COMPLETED
The Role of FDG PET in Radiation Treatment Planning for Head and Neck Cancers
Lead Sponsor:
Stanford University
Collaborating Sponsors:
McNeil Consumer & Specialty Pharmaceuticals, a Division of McNeil-PPC, Inc.
Conditions:
Head and Neck Cancer
Eligibility:
All Genders
18+ years
Brief Summary
In patients with cancer of the head and neck and rectum, knowing the exact location of the tumor is important for designing the radiation field to ensure delivery of high dose of radiation to the tumo...
Eligibility Criteria
Inclusion
- Patients who are scheduled to receive radiation therapy for head and neck cancer at Stanford.
Exclusion
- Non-Stanford patients.
Key Trial Info
Start Date :
May 1 2003
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
November 1 2007
Estimated Enrollment :
5 Patients enrolled
Trial Details
Trial ID
NCT00230269
Start Date
May 1 2003
End Date
November 1 2007
Last Update
July 12 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Stanford University School of Medicine
Stanford, California, United States, 94305